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Case Report
Transfusion Medicine
Anaphylactic Transfusion Reaction in a Patient with 
Anhaptoglobinemia: The First Case in Korea
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Anaphylactic transfusion reactions are rare complications of blood transfusions. Anhapto-
globinemia, a condition that has high incidence in Asia, can cause allergic transfusion re-
actions or anaphylaxis in severe cases. A 50-yr-old Korean woman was diagnosed with re-
lapsed acute promyelocytic leukemia. She developed thrombocytopenia during chemo-
therapy and an anaphylactic transfusion reaction on the 4th and 5th platelet transfusions 
immediately after the transfusion of the platelet concentrates was initiated. Blood analysis 
showed no detectable serum haptoglobin. We examined her genetic phenotype and de-
tected anhaptoglobinemia, which occurs because of an allelic deletion in the Hp gene clus-
ter. The presence of an antibody against haptoglobin was detected by performing ELISA. 
To prevent anaphylactic reactions, apheresis platelets were transfused after washing. Con-
sequently, anaphylactic transfusion reactions did not develop. Here, we report the first case 
of anhaptoglobinemia causing anaphylactic transfusion reaction in Korea.
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INTRODUCTION
Allergic transfusion reactions (ATRs) are the most common com-
plications of blood transfusions. ATRs present with mild to se-
vere anaphylactic reactions and lead to dyspnea, shock, loss of 
consciousness, tachycardia, and in rare cases, death. Patients 
with IgA deficiency, anhaptoglobinemia, and C3 and C4 defi-
ciencies are at an increased risk of developing ATRs because of 
the antibodies present in their plasma [1].
 Haptoglobin, synthesized by hepatocytes in the liver, is a Hb-
binding glycoprotein in the plasma. The haptoglobin phenotype 
is determined by a pair of codominant alleles-Hp1 and Hp2. 
Hence, there are 3 common genetic haptoglobin phenotypes-
Hp1 and Hp2 with a homozygous genotype; and Hp2-1 with a 
heterozygous genotype. The main function of haptoglobin is to 
prevent Hb leakage by binding to Hb [2]. Hypohaptoglobinemia 
and anhaptoglobinemia may be acquired: Reduced synthesis of 
haptoglobin due to liver dysfunction can be observed in cases 
of liver cirrhosis and hepatocellular carcinoma. Increased con-
sumption of haptoglobin for the formation of haptoglobin-Hb 
complex can be observed in cases of severe hemolysis. How-
ever, in some cases, like in the case of genetic homozygotes 
with an allelic deletion in the Hp gene cluster (Hpdel), hypohap-
toglobinemia and anhaptoglobinemia have a genetic basis [3]. 
Hp0Hp2 has also been observed to be associated with hypohap-
toglobinemia. The incidence of anhaptoglobinemia due to Hpdel 
has been reported to be about 1/1,500 among Koreans [3]. 
 We report the case of a patient who developed anaphylaxis 
after the transfusion of leukoreduced platelet concentrates (PCs). 
On the basis of the results of PCR, the patient was diagnosed 
with anhaptoglobinemia resulting from homozygous allelic Hpdel 
[4, 5]. Presence of antibody against haptoglobin was detected 
by performing ELISA. We concluded that the antibodies against 
haptoglobin led to the development of anaphylactic reaction in 
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this patient. We employed washed platelets to prevent further 
anaphylactic transfusion reactions, as this had been performed 
and demonstrated to be effective in previous studies [1, 6]. 
CASE REPORT
The Case report was approved by the Institutional Review Board 
(IRB) of the Severance Hospital. A 50-yr-old Korean woman was 
admitted to the Severance Hospital because of easy bruising 
and sore throat on September 5, 2011. She had been diagnosed 
with acute promyelocytic leukemia 3 yr ago and was confirmed 
to be in complete remission after chemotherapy. And she did 
not have liver disease or a history of hemolysis. Hematological 
analysis performed on admission showed a white blood cell 
count of 1.01×109/L, Hb level of 12.9 g/dL, and a platelet count 
of 95×109/L. Bone marrow (BM) aspiration and biopsy findings 
showed that the BM was filled with leukemic promyelocytes 
with irregular nuclear shape, dispersed chromatin, coarse azu-
rophilic granules, and occasional faggot cells. Chromosomal 
study of the BM showed that 14 out of 20 mitotic figures were 
46, XX, -6, t(15;17)(q22;12),+mar, and 6 exhibited a normal fe-
male karyotype (46, XX). The PML/RARA gene rearrangement 
in the BM was positive. Therefore, she was diagnosed with re-
lapsed acute promyelocytic leukemia. Chemotherapy with arse-
nic trioxide was initiated on September 7, 2011, and filtered PCs 
were transfused 4 times for moderate thrombocytopenia (<50 
×109/L) on days 2, 3, 5, and 9 after admission. No significant 
ATR was observed except for mild chest tightness on the 4th 
platelet transfusion. 
 On the 14th day after admission, 1 unit of platelet apheresis 
was transfused because of severe thrombocytopenia (19×109/L) 
along with an anti-histamine medication. Immediately after the 
infusion, the patient developed dyspnea, urticaria, hypotension 
(systolic blood pressure, 84 mmHg and diastolic blood pressure, 
36 mmHg), and fever (38.8°C). Discontinuation of the transfu-
sion and injection of dexamethasone with 500 mL of normal sa-
line resolved the anaphylaxis. After 2 days, her platelet count (11 
×109/L) decreased, and hence, 6 units of pooled leukoreduced 
PCs were transfused carefully along with an anti-histamine and 
dexamethasone. Although the patient was treated with premedi-
cation, the same anaphylactic reaction recurred. We surmised 
anhaptoglobinemia or IgA deficiency as the possible cause and 
analyzed her serum IgA and haptoglobulin levels. The level of 
IgA was 338 mg/dL, which is within the normal range, but se-
rum haptoglobin was undetectable. We had adopted a hapto-
globin genotyping method based on PCR. It is a simple method 
for detecting haptoglobin deletion by performing PCR. Primers 
A and B were used for amplifying the specific sequences of Hp1 
and Hp2, and primers C and D were used for amplifying the Hp2 
specific sequence. Primers Del-U and Del-L were used for am-
plifying the Hp0 allele. The haptoglobin genotype was found to 
be the Hpdel allele (Fig. 1), which causes Hpdel anhaptoglobine-
mia. Presence of an IgG antibody against the haptoglobin was 
detected by performing ELISA. In this patient, the anaphylactic 
reaction possibly occurred because of the presence of an allo-
antibody against the haptoglobin. 
 In order to prevent anaphylaxis, we decided to infuse the pa-
tient with washed and filtered PCs, which were prepared in the 
following manner: the filtered PCs were treated with 3 wash cy-
cles involving plasma supernatant removal after dilution with 
400 mL of 0.9% NaCl solution and centrifugation for 8 min at 
261.75 rad/s in a Cobe 2991 Blood Cell Processor (Cardial BCT, 
Lakewood, Colorado, USA) [7]. With gentle manual rotation, the 
Fig. 1. Determination of Hp1 and Hp2 alleles and haptoglobin gene 
deletion from the patient and control individuals in PCR. Only a 315 
bp band was amplified from the patient with homozygous for the Hp0 
allele. Lane 1, patient; lane 2, Hp2/Hp1 heterozygote; lane 3, Hp2/Hp1 
heterozygote; lane 4, Hp2/Hp0 heterozygote; lane 5, Hp2/Hp0 hetero-
zygote; lane 6, Hp2/Hp1 heterozygote.
A/B PCR
1 2 3 4 5 6
3,481 bp
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349 bp
C/D PCR
476 bp
315 bp
Hp0 PCR
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platelets in washed and filtered PCs were re-suspended and 
then placed on a washed and filtered PCs for a minimum of 30 
min before using them for transfusion. The platelet recovery was 
over 80%. We did not observe anaphylactic reactions or ATRs 
on transfusing washed and filtered red blood cells .
DISCUSSION
Because anaphylactic transfusion reactions in their most severe 
forms can cause death, every effort should be made to prevent 
such catastrophic consequences. Previous studies have shown 
that transfusion reactions can be observed in patients with IgA 
deficiency, anhaptoglobinemia, and C3 and C4 deficiencies. 
This is due to the presence of antibodies against IgA, haptoglo-
bin, and C3 and C4, resulting in the formation of antigen-anti-
body complexes [3, 8]. In Asia, the incidence of IgA deficiency 
(1/18,500) is lower than that of anhaptoglobinemia [9]. The inci-
dence of anhaptoglobinemia is reported to be about 1/1,500 in 
Korea, 1/4,000 in Japan, and 1/1,000 in China [3]. Therefore, in 
Asia, paying attention to the possible causation of anhaptoglo-
binemia in anaphylactic transfusion reactions is of paramount 
importance. This report presents the first confirmed case of ana-
phylactic reaction in anhaptoglobinemia in a Hpdel homozygote 
in Korea. 
 Screening for the presence of serum haptoglobin antibodies 
should be performed in patients at high risk of developing ge-
netic anhaptoglobinemia. A simple PCR method for detecting 
Hpdel is recommended to be a reliable method for preventing 
ATRs in genetically susceptible patients. 
 The transfusion of the plasma component present in the plate-
let product is responsible for the ATRs in these cases. Transfu-
sion of washed platelets or platelets in platelet additive solution 
is an effective way of eliminating the plasma component [10]. 
Platelet washing can also be achieved by centrifugation and re-
suspension in saline without using a washing instrument such 
as Cobe 2991 (Cardial BCT). Plasma removal by the manual 
method is reported to result in less than 10% of loss of the plate-
lets, and it does not affect the platelet function either [11]. To-
bian et al. reported that washed platelets decrease the incidence 
of ATRs [1]. We also observed that ATRs could be prevented 
simply by transfusing washed platelets in our patient with an-
haptoglobinemia.
 The incidence of anhaptoglobinemia is higher in Korea than 
in the West. Hence, when ATRs are observed to occur in pa-
tients with anhaptoglobinemia, it is important to examine if anti-
body against haptoglobin is present and to conduct a genetic 
examination. Transfusion of washed platelets is a highly effective 
treatment for patients with anhaptoglobinemia who carry an an-
tibody against haptoglobin.
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